Jonathan Allan, General Counsel & Corp Sec at Stoke Therapeutics, sold STOK on Aug 18, 2026
Data as of Oct 16
▼ SELL$86.9K2,716 shares at $32.01Jonathan Allan General Counsel & Corp SecSTOK Stoke Therapeutics, Inc.
- Traded
- Aug 18, 2026
- Disclosed
- Aug 18, 2026
- Filed
- The same day
Form 4s are due within two business days.
Official filing (SEC Form 4) ↗
The price around the disclosure
STOK since disclosure
−24.8%
after the sale
Similar stocks (XLV) since disclosure
+4.1%
XLV — its sector index fund
Change in closing price from Aug 18, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.
Our take
None of our tested rules fired on this trade.
Other trades in the same filing
- ▼ SELLJonathan Allan General Counsel & Corp SecSTOK Stoke Therapeutics, Inc.$4.7Kdisclosed Aug 18 · filed the same day